Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Navidea Biopharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security |
Security |
Fee |
Amount |
Proposed |
Maximum |
Fee |
Amount |
Equity |
Common Stock, par value $0.001 per share |
Rule 457(c) and Rule 457(h) |
6,000,000(3) |
$0.30 |
$1,800,000 |
$110.20 per $1,000,000 |
$198.36 |
Total Offering Amount |
$1,800,000 |
— |
|||||
Total Fee Offsets |
— |
||||||
Net Fee Due |
$198.36 |
(1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement (this “Registration Statement”) shall also cover any additional shares of common stock, par value $0.001 per share, of the Registrant (“Common Stock”) that become issuable under the applicable plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of shares of the Registrant’s outstanding Common Stock. |
(2) |
The proposed maximum offering price per share has been estimated in accordance with Rules 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee. The computation is based upon the average of the high and low prices of the Registrant’s Common Stock as reported on the NYSE American on December 19, 2022, which date is within five business days prior to filing this Registration Statement. |
(3) |
Represents 6,000,000 shares of the Registrant’s Common Stock that are available for issuance pursuant to the Navidea Biopharmaceuticals. Inc. 2014 Stock Incentive Plan, as amended and restated as of December 8, 2022. |